Physician
Rainbow Pediatrics
Rainbow Pediatrics was paid $5.64M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 34% of everything it billed.
33Billing provider infoRAINBOW PEDIATRICS
GEORGETOWN, DE 19947
GEORGETOWN, DE 19947
33aNPI1013076991assigned 12/07/2006
33bProvider typePediatrics Physician
28Total paid$5.64M
24GClaims268,192
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Delaware
Rank by total paid#2 of 39
Median peer was paid$418K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,869 | $131K | |
| 2019 | 34,626 | $287K | |
| 2020 | 31,103 | $1.04M | |
| 2021 | 44,575 | $1.08M | |
| 2022 | 44,264 | $1.11M | |
| 2023 | 43,472 | $1.11M | |
| 2024incomplete | 29,283 | $879K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 34% | 42,414 | 33,307 | $1.91M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.2% | 8,268 | 6,552 | $516K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 9.0% | 8,542 | 7,286 | $510K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.0% | 8,983 | 7,782 | $505K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.2% | 7,036 | 5,848 | $464K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.5% | 4,988 | 4,231 | $364K |
| 90686 | 2.7% | 12,942 | 10,810 | $151K | |
| 92551 | 1.9% | 16,679 | 14,191 | $108K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 4,208 | 3,648 | $108K |
| 99381 | 1.5% | 1,188 | 913 | $87K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 15,034 | 12,923 | $67K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 7,024 | 5,991 | $63K |
69 more codes
| 90670 | 1.0% | 4,786 | $58K | |
| 99401 | <1% | 6,165 | $54K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,768 | $46K |
| 90697 | <1% | 2,119 | $45K | |
| 90680 | <1% | 3,481 | $42K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,638 | $40K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,301 | $35K |
| 90647 | <1% | 3,010 | $32K | |
| 90633 | <1% | 2,393 | $32K | |
| 99173 | <1% | 18,056 | $28K | |
| 90651 | <1% | 2,266 | $24K | |
| 90723 | <1% | 1,993 | $22K | |
| 90620 | <1% | 1,473 | $22K | |
| 0001A | <1% | 658 | $19K | |
| 99174 | <1% | 4,893 | $19K | |
| 0002A | <1% | 630 | $19K | |
| 90734 | <1% | 1,540 | $17K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,314 | $17K |
| 96127 | <1% | 4,141 | $16K | |
| 96160 | <1% | 6,189 | $15K | |
| 90656 | <1% | 758 | $14K | |
| 90677 | <1% | 679 | $12K | |
| 90707 | <1% | 841 | $12K | |
| 90715 | <1% | 1,010 | $12K | |
| 90716 | <1% | 840 | $11K | |
| 0071A | <1% | 492 | $11K | |
| 90619 | <1% | 637 | $11K | |
| 90700 | <1% | 805 | $10K | |
| 90710 | <1% | 772 | $10K | |
| 0072A | <1% | 345 | $10K | |
| 83655 | <1% | 1,627 | $9K | |
| 90696 | <1% | 707 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,423 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 221 | $7K |
| 90672 | <1% | 526 | $6K | |
| 90681 | <1% | 407 | $6K | |
| 0003A | <1% | 201 | $5K | |
| 99188 | <1% | 352 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 712 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,646 | $2K |
| 87807 | <1% | 417 | $2K | |
| 85018 | <1% | 837 | $999.68 | |
| 0073A | <1% | 26 | $920.00 | |
| 0124A | <1% | 92 | $640.00 | |
| 97802 | <1% | 505 | $594.00 | |
| 90674 | <1% | 117 | $521.14 | |
| 81002 | <1% | 708 | $517.35 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 33 | $473.96 |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 600 | $454.43 |
| 0111A | <1% | 14 | $440.00 | |
| 90660 | <1% | 19 | $375.19 | |
| 90621 | <1% | 139 | $308.98 | |
| 0081A | <1% | 20 | $280.00 | |
| 99000 | <1% | 86 | $81.90 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 988 | $32.33 |
| 86580 | <1% | 15 | $5.00 | |
| 91307 | <1% | 932 | $2.25 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 397 | $0.00 |
| 90474 | 0% | 44 | $0.00 | |
| 36416 | 0% | 15 | $0.00 | |
| 90461 | 0% | 9,774 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 25,709 | $0.00 |
| 90685 | 0% | 130 | $0.00 | |
| 90473 | 0% | 387 | $0.00 | |
| 91300 | 0% | 1,577 | $0.00 | |
| 3725F | 0% | 397 | $0.00 | |
| 91311 | 0% | 22 | $0.00 | |
| 91308 | 0% | 40 | $0.00 | |
| 91312 | 0% | 31 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSANWAL, VIBHA (CHIEF)